These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24710115)

  • 1. Colon cancer-specific antigen-2 may be used as a detecting and prognostic marker in colorectal cancer: a preliminary observation.
    Xue G; Wang X; Yang Y; Liu D; Cheng Y; Zhou J; Cao Y
    PLoS One; 2014; 9(4):e94252. PubMed ID: 24710115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
    Leman ES; Schoen RE; Magheli A; Sokoll LJ; Chan DW; Getzenberg RH
    Clin Cancer Res; 2008 Mar; 14(5):1349-54. PubMed ID: 18316554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer.
    Walgenbach-Brunagel G; Burger B; Leman ES; Walgenbach KJ; Tolba R; Heukamp L; Hirner A; Getzenberg RH
    J Cell Biochem; 2008 May; 104(1):286-94. PubMed ID: 18044711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Evaluation of Colon Cancer Specific Antigen-2 Test and Chromocolonoscopy for Early Detection of Egyptian Patients with Colorectal Cancer.
    Elhossary M; Hawash N; Badawi R; Yousef M; Abd-Elsalam S; Elhendawy M; Wasfy R; Abou-Saif S; ElBendary A; Ismail S
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(3):302-312. PubMed ID: 31241019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical Significance of Septin 9 and Colon Cancer Specific Antigen-2 (CCSA-2) in Colorectal Cancer.
    Abd El Kader L; Soliman AH; Salem SE; Akel SY; Ibrahim NH
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):1027-1036. PubMed ID: 36974558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endosialin (TEM1) as a Diagnostic, Progression, and Prognostic Serum Marker for Patients With Colorectal Cancer-A Preliminary Study.
    Pietrzyk Ł; Wdowiak P
    Cancer Control; 2020; 27(1):1073274820903351. PubMed ID: 32107922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of RCAS1 as a biomarker in diagnosing CRC and monitoring tumor recurrence and metastasis.
    Han SX; Wang J; Wang LJ; Jin GH; Ying X; He CC; Guo XJ; Zhang JY; Zhang Y; Zhu Q
    Tumour Biol; 2014 Jun; 35(6):6149-57. PubMed ID: 24652591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.
    Leman ES; Schoen RE; Weissfeld JL; Cannon GW; Sokoll LJ; Chan DW; Getzenberg RH
    Cancer Res; 2007 Jun; 67(12):5600-5. PubMed ID: 17575123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
    Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
    Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum piRNA-54265 is a New Biomarker for early detection and clinical surveillance of Human Colorectal Cancer.
    Mai D; Zheng Y; Guo H; Ding P; Bai R; Li M; Ye Y; Zhang J; Huang X; Liu D; Sui Q; Pan L; Su J; Deng J; Wu G; Li R; Deng S; Bai Y; Ligu Y; Tan W; Wu C; Wu T; Zheng J; Lin D
    Theranostics; 2020; 10(19):8468-8478. PubMed ID: 32754257
    [No Abstract]   [Full Text] [Related]  

  • 14. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
    Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
    Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
    Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
    Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival.
    Kemper M; Hentschel W; Graß JK; Stüben BO; Konczalla L; Rawnaq T; Ghadban T; Izbicki JR; Reeh M
    Cancer Med; 2020 Mar; 9(6):2010-2018. PubMed ID: 31984657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G; Wang R; Wang M
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β
    Bengs S; Becker E; Busenhart P; Spalinger MR; Raselli T; Kasper S; Lang S; Atrott K; Mamie C; Vavricka SR; von Boehmer L; Knuth A; Tuomisto A; Mäkinen MJ; Hruz P; Turina M; Rickenbacher A; Petrowsky H; Weber A; Frei P; Halama M; Jenkins G; Sheppard D; Croner RS; Christoph J; Britzen-Laurent N; Naschberger E; Schellerer V; Stürzl M; Fried M; Rogler G; Scharl M
    Int J Cancer; 2019 Aug; 145(3):678-685. PubMed ID: 30653264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
    Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
    Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients.
    Pietrzyk Ł; Wdowiak P
    Adv Med Sci; 2019 Sep; 64(2):402-408. PubMed ID: 31352222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.